MEDICAL ADVOCATES
 IDUs
  Hepatitis C

 General Reports
Pathogenesis
 National Studies
 Prevention
 Screening/Testing
Diagnosis/Monitoring/Testing
Clinical Management
Drugs
HIV/HCV Coinfection


 
IDU Disease Main Page Main New and Noteworthy Home Page
Last Update:  December 02, 2008   
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       
         Journal Papers, Abstracts, and Commentaries
 
  High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.
Zule WA, Bobashev G.
Drug Alcohol Depend. 2008 Nov 10.
 Abstract
 
Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection:
The Influence of Time and Place.
Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C.,et al 
Am J Epidemiol. 2008 Oct 9.
 Abstract
 
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained
virological response rates in adherent patients.
Bruggmann P, Falcato L, Dober S,et al
J Viral Hepat. 2008 Jul 10.
Abstract
 
Limited uptake of hepatitis C treatment among injection drug users.
Mehta SH, Genberg BL, Astemborski J,et al  
J Community Health. 2008 Jun;33(3):126-33
 Abstract
 
Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting
drug user.
Aitken CK, Tracy SL, Revill P, 
J Clin Virol. 2008 Jan 30
Abstract
 
A prospective study to examine persistent HCV reinfection in injection drug users who
have previously cleared the virus.
Currie SL, Ryan JC, Tracy D,et al  
Drug Alcohol Depend. 2007 Oct 29;
Abstract
 
Rethinking Approaches to Risk Reduction for Injection Drug Users: Differences in Drug
Type Affect Risk for HIV and Hepatitis C Virus Infection Through Drug-Injecting Networks.
De P, Cox J, Boivin JF, Platt RW, Jolly AM  .
J Acquir Immune Defic Syndr. 2007 Aug 23;
 Abstract
 
The Association of Human Immunodeficiency Virus Infection with Spontaneously Resolved
Hepatitis C Virus Infection and Level of Viremia Among Injection Drug Users.
 Seal KH, Monto A, Dove L, et al  
Dig Dis Sci. 2007 Apr 19;
 Abstract
 
Offers of Hepatitis C Care Do Not Lead to Treatment.
Schackman BR, Teixeira PA, Beeder AB
J Urban Health. 2007 Mar 30;
 Abstract
 
Hepatitis C Treatment Candidacy and Outcomes Among 4318 US Veterans With Chronic
Hepatitis C Virus Infection: Does a History of Injection Drug Use Matter?
Seal KH, Currie SL, Shen H
J Clin Gastroenterol. 2007 Feb;41(2):199-205.
 Abstract
 
Drug abuse, innate immunity and hepatitis C virus.
 Zhang T, Li Y, Ho WZ.   
Rev Med Virol. 2006 Aug 25;16(5):311-327
 Abstract
 
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C
infection among a cohort of injecting drug users.
Amin J, Law MG, Micallef J, Jauncey M, et al
Epidemiol Infect. 2006 May 17;:1-7
 Abstract
 
Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency
Anemia Among HIV-Seropositive and HIV-Seronegative Women.
Dancheck B, Tang AM, Thomas AM, et al 
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):198-20
 Abstract
 
The impact of barriers to hepatitis C virus treatment in recovering heroin users
maintained on methadone.
Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN.  
J Subst Abuse Treat. 2005 Oct;29(3):159-65
 Abstract
 
The hepatitis C virus epidemic among injecting drug users.
Pybus OG, Cochrane A, Holmes EC, Simmonds P.
Infect Genet Evol. 2005 Mar;5(2):131-9.
 Abstract
Pathogenesis
       
         Journal Papers, Abstracts, and Commentaries
 
 
Change in hepatitis C virus genotype in injecting drug users.
Aitken C, McCaw R, Jardine D,  
J Med Virol. 2004 Oct 13;74(4):543-545
Abstract 
 
Second infection with a different hepatitis C virus genotype in a intravenous
drug user during interferon therapy.
Asselah T, Vidaud D, Doloy A, et al.
Gut 2003 Jun;52(6):900-2
 Abstract 

Hepatitis C Virus Seroconversion among Young Injection Drug Users:
Relationships and Risks.
Hahn JA, Page-Shafer K, Lum PJ, et al.  
J Infect Dis 2002 Dec 1;186(11):1558-64
 Abstract

Injection drug use facilitates hepatitis C virus infection of peripheral blood
mononuclear cells.
Resti M, Azzari C, Moriondo M, et al.
Clin Infect Dis 2002 Aug 1;35(3):236-9
 Abstract

  
Prevention
       
         Journal Papers, Abstracts, and Commentaries
 
 
Development, description, and acceptability of a small-group, behavioral intervention
to prevent HIV and hepatitis C virus Infections among young adult injection drug users.
Purcell DW, Garfein RS, Latka MH, et al
Drug Alcohol Depend. 2007 Apr 25;
Abstract 

WEEK-IN-REVIEW FEATURED REPORT
A Review of the Evidence for the Effectiveness of Primary Prevention Interventions for
Hepatitis C Among Injecting Drug Users.
Wright NM, Tompkins CN.
Harm Reduct J. 2006 Sep 6;3(1):27
 Abstract 
 
'It's Your Life!': Injecting Drug Users, Individual Responsibility and Hepatitis C
Prevention.
Fraser S. 
Health (London). 2004 Apr;8(2):199-221.
 Abstract 

Prevention and treatment of hepatitis C in injection drug users.
Edlin BR.
Hepatology 2002 Nov;36(5 Suppl):S210-9
 Abstract 

Screening/Testing
       
          Journal Papers, Abstracts, and Commentaries
 
 
Acceptability of hepatitis C virus testing methods among injecting drug users.
White B, Day C, Thein HH, et al
 Drug Alcohol Rev. 2008 Mar 31:1-5.
 Abstract

Screening for Hepatitis C in injecting drug users: a cost utility analysis.
Stein K, Dalziel K, Walker A, et al    
J Public Health Med. 2004 Mar;26(1):61-71.
 Abstract
Diagnostics/Monitoring/Testing
       

          Journal Papers, Abstracts, and Commentaries

 
Failure to diagnose recent hepatitis C virus infections in London injecting
drug users.
Aarons E, Grant P, Soldan K, et al 
Med Virol. 2004 Aug;73(4):548-53.
 Abstract

Finding a vein or obtaining consent: a qualitative study of hepatitis C
testing in GP methadone clinics.
Perry M, Chew-Graham C.
Fam Pract. 2003 Oct;20(5):538-44
 Abstract
Clinical Management
Drugs      
General Reports

           Journal Papers, Abstracts, and Commentaries
 
 
Predictors of treatment for hepatitis C virus (HCV) infection in drug users.
Reed C, Stuver SO, Tumilty S,  et al   
Subst Abus. 2008;29(1):5-15.
 Abstract
 
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance
patients.
Novick DM, Kreek MJ. 
Addiction. 2008 Apr 16
Abstract
 
Liver transplant and hepatitis C in methadone maintenance therapy: a case report.
Hancock MM, Prosser CC, Ransibrahmanakul K, et al 
Subst Abuse Treat Prev Policy. 2007 Feb 1;2(1):5
Abstract
 
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous
naltrexone implants.
 Jeffrey GP, MacQuillan G, Chua F, et al 
Hepatology. 2007 Jan;45(1):3-5.
 Abstract
 
font A WEEK-IN-REVIEW FEATURED REPORT
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous
naltrexone implants.
 Jeffrey GP, Macquillan G, Chua F, et al
Hepatology. 2006 Dec 22;45(1):111-117
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT PDF ARTICLE
 Therapeutic challenges in hepatitis C-infected injection drug using patients.
Cooper CL, Mills EJ.
Harm Reduct J. 2006 Nov 10;3(1):31
Paper
 
Guidelines for the treatment of hepatitis C virus infection in injection drug users: status
quo in the European union countries.
Reimer J, Schulte B, Castells X, et al 
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S373-8
 Abstract
 
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV)
infection among young HCV-infected injection drug users.
Strathdee SA, Latka M, Campbell J, et al 
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S304-12
 Abstract
 
Factors Associated with Interest in Initiating Treatment for Hepatitis C Virus (HCV)
Infection among Young HCV-Infected Injection Drug Users.
 Strathdee SA, Latka M, Campbell J, et al   
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S304-12.
Abstract
 
Injection Drug Use and the Hepatitis C Virus: Considerations for a Targeted
Treatment Approach--The Case Study of Canada.
Fischer B, Haydon E, Rehm J, et al.
J Urban Health. 2004 Sep;81(3):428-447.
 Abstract  

Treating hepatitis C in methadone maintenance patients: an interim analysis.
Sylvestre DL.
Drug Alcohol Depend 2002 Jul 1;67(2):117-23
Abstract  
 
Severity and correlates of liver disease in hepatitis C virus-infected injection
drug users.
Rai R, Wilson LE,  Astemborski J, et al.
Hepatology 2002 May;35(5):1247-125
 Abstract 
  
Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years' Follow-Up .
Dalgard O, Bjoro K, Hellum K , et al.
Eur Addict Res 2002 Jan;8(1):45-49
 Abstract

Treatment of hepatitis C infection in injection drug users.
Backmund M, Meyer K, Von Zielonka M, Eichenlaub D.
 Hepatology 2001 Jul;34(1):188-93
 Abstract
 
Managing chronic hepatitis C acquired through intravenous drug use.
Jowett SL, Agarwal K, Smith BC, et al.
QJM 2001 Mar;94(3):153-8
 Abstract   
 

 
          Conference Reports, Abstracts, and Posters
 
  CONFERENCE PRESENTATION
 Injection Drug Use and Hepatitis
 Edlin BR
 NIH Consensus Development Conference on  Management of Hepatitis C: 2002]
 Report
 

         
         Conference Reports, Abstracts, and Posters

  Is Illicit Drug Use a Risk Factor for Non-Adherence to Antiretroviral Therapy? 
K.A. Gebo, J C. Keruly, R.D Moore.
(8 CROI)
 Abstract		  

IDU Disease Main Page Main New and Noteworthy Home Page

IDU Health: Hepatitis C